Charles A. Leath

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 25 papers. Top paper: “Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279”.

Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279

Journal of Clinical Oncology(2024)10.1200/jco.23.02235

N/A

0.637DataRank · unranked

19 citations

Wei Deng, I. Peterson, Robert S. Mannel, J. S. Thompson, Elizabeth Lokich +12 more

Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: results from NRG Oncology/GOG-263/KGOG 1008

Annals of Oncology(2025)10.1016/j.annonc.2025.09.003

N/A

0.491DataRank · unranked

14 citations

Wei Deng, Kevin Albuquerque, W-J Koh, Jyoti Mayadev, A. Heugel +15 more

OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.04.578

N/A

0.399DataRank · unranked

12 citations

Debra L. Richardson, Andrea R. Hagemann, Robert W. Holloway, Mark S. Reed, Melanie K Bergman +21 more

Systematic Next Generation Sequencing is feasible in clinical practice and identifies opportunities for targeted therapy in women with uterine cancer: Results from a prospective cohort study

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.07.017

N/A

0DataRank · unranked

15 citations

Nidhi Goel, B.M. Roane, McKenzie E. Foxall, Jhalak Dholakia, Angelina I. Londoño +4 more

The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.07.002

N/A

0DataRank · unranked

34 citations

Qin Zhou, Benny Brandt, Alexia Iasonos, Vasileios Sioulas, Katherine LaVigne Mager +32 more

Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications

Current Oncology Reports(2022)10.1007/s11912-022-01221-3

N/A

0DataRank · unranked

18 citations

Alexander C. Cohen, Charles A. Leath, Elizabeth Evans, Ronald D. Alvarez, Premal H. Thaker +1 more

Trial in progress: Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: Groningen International Study on Sentinel Nodes in Vulvar Cancer III (GROINSS-V III/NRG-GY024).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps5624

N/A

0DataRank · unranked

0 citations

Brian M. Slomovitz, Mario M. Leitão, Ate G.J. van der Zee, Carien L. Creutzberg, A.K.L. Reyners +6 more

Use of a mobile health patient engagement technology improves perioperative outcomes in gynecologic oncology patients

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.09.008

N/A

0DataRank · unranked

7 citations

Austin B. Gardner, Daniel I. Chu, Charles A. Leath, J. Michael Straughn, Haller J. Smith +1 more

Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations—A Qualitative Study

Cancer Prevention Research(2023)10.1158/1940-6207.capr-23-0303

N/A

0DataRank · unranked

6 citations

Jose Alejandro Rauh‐Hain, J.J. Rubio García, Norma de Aguinaga, Mary Anne Powell, Sylvia Peral +7 more

Incorporation of triapine (T) with cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5502

N/A

0DataRank · unranked

13 citations

Wei Deng, Loren K. Mell, Debra L. Richardson, Joan L. Walker, Laura L. Holman +15 more

Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5525

N/A

0DataRank · unranked

1 citations

Andrew B. Nixon, Danielle Enserro, David Bender, B.J. Rimel, Matthew A. Powell +12 more

A randomized phase II study comparing single-agent olaparib, single-agent cediranib, and the combinations of cediranib/olaparib, olaparib/durvalumab (MEDI4736), cediranib/durvalumab (MEDI4736), and olaparib/AZD5363 (capivasertib) in women with recurrent, persistent, or metastatic endometrial cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps5629

N/A

0DataRank · unranked

1 citations

David Bender, Danielle Enserro, Shannon N. Westin, Debra L. Richardson, Laura L. Holman +10 more

Cascade genetic testing: an underutilized pathway to equitable cancer care?

Familial Cancer(2024)10.1007/s10689-024-00367-2

N/A

0DataRank · unranked

11 citations

Erica M. Bednar, Sara Pirzadeh‐Miller, Sayoni Lahiri, Isabel C. Scarinci, Charles A. Leath +4 more

Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.01.009

N/A

0DataRank · unranked

9 citations

Chunqiao Tian, Yovanni Casablanca, Nicholas W. Bateman, Suzanne Jokajtys, Calen Kucera +20 more

Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.026

N/A

0DataRank · unranked

6 citations

Chunqiao Tian, Jordyn Tumas, Neil T. Phippen, Christopher M. Tarney, Erica Hope +22 more

Impact of steroid use and glycemic control on postoperative complications in diabetic gynecologic oncology patients undergoing laparotomy

Gynecologic Oncology Reports(2024)10.1016/j.gore.2024.101344

N/A

0DataRank · unranked

1 citations

Teresa Boitano, Matthew Scalise, Samantha Patton, Charles A. Leath, J. Michael Straughn +2 more

Dedicated research navigators: a tool to decrease disparities in clinical trial enrollment?

International Journal of Gynecological Cancer(2024)10.1016/j.ijgc.2024.100066

N/A

0DataRank · unranked

1 citations

Jaclyn Wall, Lia Bos, Gabrielle B. Rocque, Courtney Williams, Haller J. Smith +5 more

Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial

Nature Communications(2025)10.1038/s41467-024-55200-2

N/A

0DataRank · unranked

18 citations

Dmitriy Zamarin, Wei Deng, Heather A. Lankes, Giulio Pesci, Hayeon Kim +19 more

Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.02.001

N/A

0DataRank · unranked

8 citations

Ernst Lengyel, Andrea E. Wahner Hendrickson, Gustavo C. Rodriguez, Charles A. Leath, Rodney P. Rocconi +6 more

Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-0263)

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.09.014

N/A

0DataRank · unranked

3 citations

Helen Huang, Wei Deng, Wui‐Jin Koh, William H. Rodgers, William Small +17 more

Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer

Brachytherapy(2025)10.1016/j.brachy.2025.09.011

N/A

0DataRank · unranked

2 citations

Wei Deng, Dmitriy Zamarin, Ying Xiao, Junzo Chino, Stanley Benedict +18 more

Novel Therapeutics for Recurrent Cervical Cancer: Moving Towards Personalized Therapy

Drugs(2020)10.1007/s40265-019-01249-z

N/A

0DataRank · unranked

102 citations

B.M. Roane, Charles A. Leath, Alexander C. Cohen

105P Immune biomarker analysis of the OVATION-2 trial, a randomized phase I/II study of IL-12 gene therapy IMNN-001 in combination with neo/adjuvant chemotherapy (NACT) in newly-diagnosed advanced epithelial ovarian cancer (EOC)

ESMO Open(2025)10.1016/j.esmoop.2025.105233

N/A

0DataRank · unranked

1 citations

Debra L. Richardson, Andrea R. Hagemann, Robert W. Holloway, Bhavana Pothuri, Jennifer Scalici +14 more

A Multi-atlas Approach for Active Bone Marrow Sparing Radiation Therapy: Implementation in the NRG-GY006 Trial

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.06.071

N/A

0DataRank · unranked

20 citations

Austin Miller, Ana Medina-Palomo, Casey W. Williamson, Hannah Nguyen, Jessica Lowenstein +9 more

Gynecologic oncology patients are ready for telemedicine in routine care: Results from a pre-COVID survey

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100871

N/A

0DataRank · unranked

21 citations

J. Kim, Margaret Liang, Rebecca C. Arend, Kerri S. Bevis, J. Michael Straughn +4 more